Replacement of the quinoline system in 2-phenyl-4-quinolinecarboxamide NK-3 receptor antagonists

Farmaco

Volumn 54, Issue 6, 1999, Pages 364-374

  Giardina, G A M ^a   Artico, M ^a   Cavagnera, S ^a   Cerri, A ^a   Consolandi, E ^a   Gagliardi, S ^a   Graziani, D ^a   Grugni, M ^a   Hay, D W P ^b   Luttmann, M A ^b   Mena, R ^a   Raveglia, L F ^a   Rigolio, R ^a   Sarau, H M ^b   Schmidt, D B ^b   Zanoni, G ^a   Farina, C ^a  

^a SmithKline Beecham SpA   (Italy)

^b SmithKline Beecham P ^*  (United States)

Author keywords

2 Phenyl 4 quinolinecarboxamides; Neurokinin B; Neurokinin 3 receptor antagonists; Tachykinins

Indexed keywords

NAPHTHALENE; NEUROKININ 3 RECEPTOR ANTAGONIST; QUINOLINE;

ARTICLE; BINDING AFFINITY; DRUG BINDING;

ANIMALS; BINDING, COMPETITIVE; CHO CELLS; CLONING, MOLECULAR; CRICETINAE; HUMANS; QUINOLINES; RADIOLIGAND ASSAY; RECEPTORS, NEUROKININ-3; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0033617969     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-827X(99)00043-9     Document Type: Article

References (28)

1. Maggi C.A., Patacchini R., Rovero P., Giachetti A. Tachykinin receptors and tachykinin receptor antagonists. J. Auton. Pharmacol. 13:1993;23-93.
2. Maggio J.E. Tachykinins. Annu. Rev. Neurosci. 11:1988;13-28.
3. Swain C.J. Neurokinin receptor antagonists. Exp. Opin. Ther. Patents. 6:1996;367-378.
4. Elliott J., Seward E. Neurokinin receptor antagonists. Exp. Opin. Ther. Patents. 7:1997;43-54.
5. Boden P., Eden J.M., Hodgson J., Horwell D.C., Howson W., Hughes J., McKnight A.T., Meecham K., Pritchard M.C., Raphy J., Ratcliffe G.S., Suman-Chauhan N., Woodruff G.N. The rational development of small molecule tachykinin NK3 receptor antagonists - the utilization of a dipeptide chemical library in drug design. Bioorg. Med. Chem. Lett. 4:1994;1679-1684.
6. Emonds-Alt X., Bichon D., Ducoux J.P., Heaulme M., Miloux B., Poncelet M., Proietto V., Van Broeck D., Vilain P., Neliat G., Soubrié P., Le Fur G., Breliere J.C. SR 142801, the first potent non-peptide antagonist of the tachykinin NK3 receptor. Life Sci. 56:1995;PL27-PL32.
7. Oury-Donat F., Carayon P., Thurneyssen O., Pailhon V., Emonds-Alt X., Soubrié P., Le Fur G. Functional characterization of the nonpeptide neurokinin 3 (NK3) receptor antagonist, SR 142801 on the human NK3 receptor expressed in Chinese hamster ovary cells. J. Pharmacol. Exp. Ther. 274:1995;148-154.
8. S.K. Shah (18.07.95), US Patent 5,434,158, CA: 123, 218432x.
9. Boden P., Eden J.M., Hodgson J., Horwell D.C., Hughes J., McKnight A.T., Lewthwaite R.A., Pritchard M.C., Raphy J., Meecham K., Ratcliffe G.S., Suman-Chauhan N., Woodruff G.N. Use of a dipeptide chemical library in the development of non-peptide tachykinin NK3 receptor selective antagonists. J. Med. Chem. 39:1996;1664-1675.
10. Giardina G.A.M., Sarau H.M., Farina C., Medhurst A.D., Grugni M., Foley J.J., Raveglia L.F., Schmidt D.B., Rigolio R., Vassallo M., Vecchietti V., Hay D.W.P. 2-Phenyl-4-quinolinecarboxamides: a novel class of potent and selective non-peptide competitive antagonists for the human Neurokinin-3-receptor. J. Med. Chem. 39:1996;2281-2284.
11. Giardina G.A.M, Sarau H.M., Farina C., Medhurst A.D., Grugni M., Raveglia L.F., Schmidt D.B., Rigolio R., Luttmann M., Vecchietti V., Hay D.W.P. Discovery of a novel class of selective non-peptide antagonists for the human neurokinin-3 receptor. 1. Identification of the 4-quinolinecarboxamide framework. J. Med. Chem. 40:1997;1794-1807.
12. Pritchard M.C., Boden P. Tachykinin NK3 receptor: biology and development of selective peptide and nonpeptide ligands. Drugs Fut. 20:1995;1163-1173.
13. Giardina G.A.M., Raveglia L.F. Neurokinin-3 receptor antagonists. Exp. Opin. Ther. Patents. 7(4):1997;307-323.
14. Blumbergs P., La Montagne M.P., Markovac A. Antimalarials. 2. 2,6-Bis(aryl)-4-pyridinemethanols. J. Med. Chem. 15:1972;808-812.
15. Batt D.G., Houghton G.C. Polyfunctional pyridines from nitroacetamidine and β-diketones. A useful synthesis of substituted imidazo[4,5-b]pyridines and related compounds. J. Heterocycl. Chem. 32:1995;963-969.
16. CAUTION: great attention must be paid in each step of the described preparation of methazonic acid (Ref. [15]), an explosive intermediate in the synthesis of nitroacetamidine 21; in particular, crude methazonic acid should be maintained in ethereal solution after careful in vacuo concentration to a reduced volume, rigorously performed at a temperature below 20°C.
17. M.C. Venuti, 2,3-Dihydroxy-1,4-dioxane: a stable synthetic equivalent of anhydrous glyoxal, Synthesis (1982) 61-63.
18. Batt D.G., Copeland R.A., Dowling R.L., Gardner T.C., Jones E.A., Orwat M.J., Pinto D.J., Pitts W.J., Magolda R.L., Jaffee B.D. Immunosuppressive structure-activity relationships of Brequinar and related cinchoninic acid derivatives. Bioorg. Med. Chem. Lett. 5:1995;1549-1554.
19. 1H NMR: a little but clear NOE was observed between methyl protons and hydrogens in position ortho of the 2-phenyl group.
20. Bergman J., Carlsson R., Sjöberg B. The reaction of indole Grignard reagent with phosgene. A facile synthesis of indole 3-carboxylic acid derivatives. J. Heterocyclic Chem. 14:1977;1123-1134.
21. Burger U., Bringhen A.O. Cyclization studies with N-Mannich bases of 2-substituted indoles. Helv. Chim. Acta. 72:1989;93-100.
22. Plattner J.J., Parks J.A. Preparation of new dihydrofuro[2,3-f]indole derivatives. J. Heterocycl. Chem. 20:1983;1059-1062.
23. Buell G., Schulz M.F., Arkinstall S.J., Maury K., Missotten M., Adami N., Talabot F., Kawashima E. Molecular characterization, expression and localization of human NK-3 receptor. FEBS Lett. 299:1992;90-95.
24. Sarau H.M., Griswold D.E., Potts W., Foley J.J., Schmidt D.B., Webb E.F., Martin L.D., Brawner M.E., Elshourbagy N.A., Medhurst A.D., Giardina G.A.M., Hay D.W.P. Nonpeptide tachykinin receptor antagonists.1. Pharmacological and pharmacokinetic characterization of SB 223412, a novel, potent and selective NK-3 receptor antagonist. J. Pharmacol. Exp. Ther. 281:1997;1303-1311.
25. Sadowski S., Huang R-R.C., Fong T.M., Marko O., Cascieri M.A. Characterization of the binding of [125I-iodo-histidyl, methyl-Phe7] neurokinin B to the neurokinin-3 receptor. Neuropeptides. 24:1993;317-319.
26. 50) of an enzymatic reaction. Biochem. Pharmacol. 22:1973;3099-3108.
27. Bennet G.B., Mason R.B. The regioselective behavior of unsaturated keto esters towards vinylogous amides. J. Org. Chem. 42:1977;1919-1922.
28. Batt D.G., Houghton G.C. Functional pyridines from nitroacetamidine and β-diketones. A useful synthesis of substituted imidazo[4,5-b]pyridines and related compounds. J. Het. Chem. 32:1995;963-969.